Chemoinformaics analysis of Y-L-Glutamyl-Alpha-Amino-B-(2-Methylene-Cyclopropyl)-Propionic-Acid
Molecular Weight | 270.285 | nRot | 8 |
Heavy Atom Molecular Weight | 252.141 | nRig | 7 |
Exact Molecular Weight | 270.122 | nRing | 1 |
Solubility: LogS | -1.063 | nHRing | 0 |
Solubility: LogP | -2.173 | No. of Aliphatic Rings | 1 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 38.2523 |
nHD | 4 | BPOL | 20.6617 |
QED | 0.449 |
Synth | 3.444 |
Natural Product Likeliness | 1.439 |
NR-PPAR-gamma | 0.065 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.016 |
HIA | 0.061 |
CACO-2 | -6.285 |
MDCK | 0.00255494 |
BBB | 0.268 |
PPB | 0.276958 |
VDSS | 0.247 |
FU | 0.739964 |
CYP1A2-inh | 0.001 |
CYP1A2-sub | 0.016 |
CYP2c19-inh | 0.032 |
CYP2c19-sub | 0.037 |
CYP2c9-inh | 0.104 |
CYP2c9-sub | 0.634 |
CYP2d6-inh | 0.017 |
CYP2d6-sub | 0.146 |
CYP3a4-inh | 0.012 |
CYP3a4-sub | 0.009 |
CL | 2.661 |
T12 | 0.85 |
hERG | 0.01 |
Ames | 0.016 |
ROA | 0.058 |
SkinSen | 0.049 |
Carcinogencity | 0.43 |
EI | 0.02 |
Respiratory | 0.132 |
NR-Aromatase | 0.004 |
Antiviral | Yes |
Prediction | 0.726704 |